Revamp Medical
Catheter-based Solution for Acute Decompensated Heart Failure
Company Overview
Snapshot
Founded in January 2016 by Lihu Avitov and Rafi Benary, Revamp Medical operates with 11–50 employees. The company has raised $57K across three funding rounds and secured a Series A financing round in May 2023, led by KCK Medtech.
Business overview
Revamp Medical is a Health Tech & Life Sciences company focused on addressing unmet needs in Acute Heart Failure patients. The company develops the DORAYA catheter, a temporary venous catheter system designed to improve the efficacy of diuretic therapy by regulating vascular hemodynamics. This product targets patients with acute heart failure, including those with diuretic resistance, by managing venous hemodynamics, central venous pressure, renal afterload, and venous returns. Revamp Medical serves healthcare providers, including doctors and hospitals, within the medical devices, cardiology, and medical treatment & therapeutics sectors globally.
Strategic signal
In May 2023, Revamp Medical secured Series A funding led by. This investment is crucial as it will support the continued development of the company's clinical program for Heart Failure congestion management, signaling strong investor confidence in the DORAYA catheter's potential to address a significant medical need and advance its market readiness.
Log in to access full profile ›Company Intelligence Q&A
- What is Revamp Medical's primary product?
- Revamp Medical's primary product is the DORAYA catheter, a temporary venous catheter system designed to improve the efficacy of diuretic therapy in patients with acute heart failure.
- When was Revamp Medical founded and by whom?
- Revamp Medical was founded in January 2016 by Lihu Avitov and Rafi Benary.
- Has Revamp Medical received any significant regulatory designations for its product?
- Yes, in July 2020, Revamp Medical's DORAYA acute heart failure catheter received FDA breakthrough device designation.
- Which investors participated in Revamp Medical's Series A funding round?
- In May 2023, Revamp Medical secured Series A funding led by.
- What is the purpose of the DORAYA catheter?
- The DORAYA catheter is designed to be deployed temporarily in the infrarenal IVC for up to 12 hours, helping cardiologists manage venous hemodynamics, central venous pressure, renal afterload, and venous returns in acute heart failure patients.